Table 2.
Characteristic | MSSA (N=2825) |
MRSA (N=1063) |
P Value |
---|---|---|---|
Gestational age, weeks | .72 | ||
<25 | 723 (26) | 270 (25) | |
26–28 | 966 (34) | 345 (32) | |
29–32 | 660 (23) | 2659 (24) | |
33–36 | 253 (9) | 107 (10) | |
≥37 | 219 (8) | 82 (8) | |
Birth weight, g | .42 | ||
<1000 | 1480 (52) | 528 (50) | |
1000–1499 | 689 (24) | 284 (27) | |
1500–2499 | 387 (14) | 145 (14) | |
2500–3499 | 194 (7) | 82 (8) | |
>3500 | 73 (3) | 24 (2) | |
Apgar score | .24 | ||
0-3 | 147 (5) | 49 (5) | |
4-6 | 512 (19) | 215 (21) | |
7-10 | 2087 (76) | 762 (74) | |
Race/ethnicity | <.001 | ||
White | 1329 (49) | 467 (45) | |
African American | 681 (25) | 330 (32) | |
Hispanic | 564 (21) | 201 (19) | |
Other | 151 (6) | 37 (4) | |
Male | 1555 (55) | 575 (54) | .60 |
Inborn | 2236 (80) | 783 (74) | <.001 |
Cesarean section | 2033 (73) | 741 (71) | .16 |
Small for gestational age | 541 (19) | 207 (20) | .84 |
Congenital anomaly | 363 (13) | 150 (14) | .30 |
Age at 1st positive culture, days |
.01 | ||
<7 | 324 (11) | 123 (12) | |
7–14 | 659 (23) | 292 (27) | |
15–28 | 905 (32) | 348 (33) | |
>28 | 937 (33) | 300 (28) | |
Previous surgical procedure |
476 (17) | 186 (18) | .63 |
Inotropic supportb | 0 (0, 2) | 0 (0, 2) | .61 |
Oxygen supportb | 8 (1, 20) | 5 (1, 15) | <.001 |
Ventilator supportb | 5 (0, 16) | 5 (1, 13) | .06 |
Antibiotic exposureb | 4 (1, 11) | 4 (1, 10) | .62 |
Anti-MRSA antibiotic exposureb |
0 (0, 4) | 0 (0, 3) | .52 |
Abbreviations: MRSA, methicillin-resistant S. aureus; MSSA, methicillin-susceptible S. aureus.
Except where indicated, data are presented as no. (%). Invasive cultures = blood, cerebrospinal fluid, abscess and sterile sites. For infants with more than one infection, only the first invasive infection was evaluated.
Median (25th, 75th percentiles) number of days with exposure prior to first invasive Staphylococcus aureus infection.